Medical device news covering implants, diagnostics, recalls, FDA clearances, and medtech company performance.
Corewell Health in Royal Oak, Michigan, performed the world's first documented single-port robotic mitral valve repair on 60-year-old Patrick O'Brien. The technique uses one port and one small incision, compared to the traditional five-port method, potentially reducing recovery time and scarring.
Stryker announced the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacements. The stock is down 17% over the past year but appears undervalued at current levels.
MDT introduced the TMR1370 magnetic switch IC for continuous glucose monitors, enabling over two years of standby operation. The chip draws only 30nA typical supply current and comes in a miniature 1.6×1.6×0.5mm package. Samples are available now.
RapidPulse secured $48 million in Series B funding co-led by Medtronic, TechWald Next, and S3 Ventures. The funds will support the TURBO study, an investigational device exemption trial for its stroke aspiration system designed to improve clot removal in acute ischaemic stroke patients.
This commentary argues that Intuitive Surgical's 35% stock decline is a temporary setback, citing the company's strong annuity-like revenue from services and instruments. It suggests that history supports buying on dips for growth stocks, though it acknowledges the high valuation risk.
Intuitive Surgical reported Q2 Non-GAAP EPS of $2.80, beating estimates by $0.30. Revenue reached $2.89B, up 19% year-over-year. The company placed 468 da Vinci systems in Q2, up from 395 a year ago. GAAP net income was $818M ($2.29 per share), compared to $658M ($1.81) in Q2 2025.
Elutia agreed to sell its SimpliDerm business to Cellution Biologics for up to $11 million, including $8 million cash at closing. The sale completes Elutia's strategic review and allows it to focus on advancing NXT-41x, an antibiotic-eluting biomatrix for plastic and reconstructive surgery, toward a 2027 launch.
U.S. Army medics in Europe are testing the i-STAT Alinity, a handheld device that can detect traumatic brain injuries in 15 minutes by measuring biomarkers in blood. The tool is being integrated into air defense forward units under the 10th Army Air and Missile Defense Command.
Saluda Medical announced the first U.S. surgical cases using the FDA-approved Evoke CAP24 paddle lead, performed on July 10 and July 14. The procedures were done by Dr. Erika A. Petersen and Dr. Steven M. Falowski. CAP24 is the first spinal cord stimulation paddle lead engineered for closed-loop neuromodulation.
Catholic Health and GE HealthCare announced a 10-year strategic partnership valued at approximately $500 million to expand patient access to advanced imaging, diagnostics, and AI-enabled technology across Long Island. The deal will add over 1,300 pieces of technology, with about half expected in the first three years, and generate capital savings versus traditional purchasing.